Murine polyomavirus virus-like particles carrying full-length human PSA protect BALB/c mice from outgrowth of a PSA expressing tumor.
Virus-like particles (VLPs) consist of capsid proteins from viruses and have been shown to be usable as carriers of protein and peptide antigens for immune therapy. In this study, we have produced and assayed murine polyomavirus (MPyV) VLPs carrying the entire human Prostate Specific Antigen (PSA) (...
Main Authors: | Mathilda Eriksson, Kalle Andreasson, Joachim Weidmann, Kajsa Lundberg, Karin Tegerstedt, Tina Dalianis, Torbjörn Ramqvist |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3157473?pdf=render |
Similar Items
-
CD4+ and CD8+ T cells can act separately in tumour rejection after immunization with murine pneumotropic virus chimeric Her2/neu virus-like particles.
by: Kalle Andreasson, et al.
Published: (2010-01-01) -
Osäkerhetsanalys av PSA-resultat : Metodutveckling och parameterinventeringför osäkerhetsanalys av PSA-resultat
by: Eriksson, Carl
Published: (2017) -
Performance of PSA and of PSA density in the diagnosis of prostate carcinoma
by: Antonio Carlos Pereira Martins, et al.
Published: (2002-01-01) -
Total PSA and free PSA in patients with severe liver dysfunction
by: Rama Devi Mittal, et al.
Published: (2003-01-01) -
Relation between Serum Level of Total PSA and Free PSA/Total PSA Ratio with Grade of Prostate Cancer
by: Mohammad Yazdani, et al.
Published: (2013-10-01)